Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0482
+0.0011 (2.29%)
Jul 1, 2025, 3:50 PM EDT

Nu-Med Plus Statistics

Total Valuation

Nu-Med Plus has a market cap or net worth of 4.03 million. The enterprise value is 4.12 million.

Market Cap 4.03M
Enterprise Value 4.12M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

Nu-Med Plus has 83.55 million shares outstanding. The number of shares has increased by 1.61% in one year.

Current Share Class 83.55M
Shares Outstanding 83.55M
Shares Change (YoY) +1.61%
Shares Change (QoQ) -7.32%
Owned by Insiders (%) 45.04%
Owned by Institutions (%) n/a
Float 45.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -17.13
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -62.07
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio 0.02
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.29

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -541.42%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 26.15%
Revenue Per Employee n/a
Profits Per Employee -33,226
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.86% in the last 52 weeks. The beta is -2.64, so Nu-Med Plus's price volatility has been lower than the market average.

Beta (5Y) -2.64
52-Week Price Change -34.86%
50-Day Moving Average 0.05
200-Day Moving Average 0.04
Relative Strength Index (RSI) 46.27
Average Volume (20 Days) 6,664

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -61,452
Pretax Income -66,452
Net Income -66,452
EBITDA n/a
EBIT -61,452
Earnings Per Share (EPS) -0.00
Full Income Statement

Balance Sheet

The company has 2,373 in cash and 100,000 in debt, giving a net cash position of -97,627 or -0.00 per share.

Cash & Cash Equivalents 2,373
Total Debt 100,000
Net Cash -97,627
Net Cash Per Share -0.00
Equity (Book Value) -235,029
Book Value Per Share -0.00
Working Capital -235,029
Full Balance Sheet

Cash Flow

Operating Cash Flow -3,983
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Nu-Med Plus does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.61%
Shareholder Yield n/a
Earnings Yield -1.65%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1